Huadong Medicine Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Cash & Equivalents	3,735	4,978	5,276	4,663	3,996	4,032
Short-Term Investments	-	75.46	-	-	-	-
Cash & Short-Term Investments	3,735	5,054	5,276	4,663	3,996	4,032
Cash Growth	0.62%	-4.23%	13.15%	16.69%	-0.90%	26.09%
Accounts Receivable	11,409	9,452	10,114	8,896	8,210	6,940
Other Receivables	609.9	518.44	402.96	291.14	284.18	223.92
Receivables	12,019	9,971	10,517	9,188	8,494	7,164
Inventory	5,328	5,536	4,776	4,290	4,495	3,975
Prepaid Expenses	-	-	-	15.07	-	-
Other Current Assets	722.9	667.24	482.3	340.46	582.21	316.04
Total Current Assets	21,804	21,227	21,052	18,497	17,568	15,487
Property, Plant & Equipment	5,480	5,473	5,409	5,204	5,021	4,813
Long-Term Investments	2,312	2,190	2,147	2,101	2,020	1,243
Goodwill	2,848	2,860	2,913	2,599	2,441	2,139
Other Intangible Assets	3,922	3,850	3,645	2,334	2,280	2,233
Long-Term Deferred Tax Assets	385.08	385.08	221.85	187.81	152.84	143.65
Long-Term Deferred Charges	1,962	1,777	1,056	1,013	657.81	12.43
Other Long-Term Assets	1,195	1,276	1,436	1,574	1,051	925.63
Total Assets	39,908	39,038	37,879	33,509	31,192	26,996
Accounts Payable	7,610	7,970	7,044	6,102	5,902	4,520
Accrued Expenses	237.14	559.53	650.63	554.92	518.92	920.63
Short-Term Debt	1,715	1,675	2,665	1,197	1,337	1,627
Current Portion of Long-Term Debt	82.98	37.1	212.41	80.92	36.9	174.18
Current Portion of Leases	-	69.19	67.3	81.98	75.29	66.86
Current Income Taxes Payable	553.76	365.9	370.26	259.27	154.95	261.24
Current Unearned Revenue	232.36	189.35	174.72	136.85	147.64	119.49
Other Current Liabilities	2,603	2,225	2,610	2,389	1,979	1,576
Total Current Liabilities	13,033	13,091	13,794	10,803	10,153	9,266
Long-Term Debt	251.62	252.03	14.26	520.76	1,051	139.18
Long-Term Leases	111.06	88.81	71.86	56.7	84.61	80.89
Long-Term Unearned Revenue	187.36	190.94	183.86	171.06	126.12	83.52
Long-Term Deferred Tax Liabilities	217.24	223.96	197.38	184.37	202.08	184.91
Other Long-Term Liabilities	19.92	20.62	53.7	191.61	398.67	300.99
Total Liabilities	13,820	13,867	14,315	11,927	12,016	10,055
Common Stock	1,754	1,754	1,754	1,754	1,754	1,750
Additional Paid-In Capital	2,417	2,416	2,551	2,446	2,378	2,230
Retained Earnings	21,638	20,635	18,852	16,972	14,639	12,647
Treasury Stock	-	-	-46.8	-84.52	-104.65	-
Comprehensive Income & Other	-74.84	5.77	-50.6	-40.34	-88.55	-47.77
Total Common Equity	25,733	24,811	23,060	21,048	18,578	16,579
Minority Interest	354.64	359.67	503.7	534.65	598.52	361.94
Shareholders' Equity	26,088	25,171	23,564	21,582	19,176	16,941
Total Liabilities & Equity	39,908	39,038	37,879	33,509	31,192	26,996
Total Debt	2,160	2,122	3,031	1,938	2,586	2,089
Net Cash (Debt)	1,575	2,931	2,246	2,726	1,411	1,944
Net Cash Growth	50.78%	30.53%	-17.61%	93.21%	-27.43%	62.16%
Net Cash Per Share	0.90	1.67	1.28	1.56	0.81	1.11
Filing Date Shares Outstanding	1,754	1,754	1,759	1,752	1,750	1,750
Total Common Shares Outstanding	1,754	1,754	1,759	1,752	1,750	1,750
Working Capital	8,771	8,137	7,258	7,694	7,415	6,221
Book Value Per Share	14.67	14.15	13.11	12.01	10.62	9.47
Tangible Book Value	18,963	18,102	16,502	16,115	13,856	12,207
Tangible Book Value Per Share	10.81	10.32	9.38	9.20	7.92	6.98
Buildings	-	2,610	2,483	2,299	1,865	1,503
Machinery	-	5,355	5,010	4,438	4,282	3,385
Construction In Progress	-	832.43	836.74	913.15	873.16	1,582

Source: S&P Global Market Intelligence. Standard template. Financial Sources.